Internal Medicine, Hematology & Oncology · Flushing, NY
NPI
1598709388
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
42 35 Main St # 3h
Flushing, NY, 11355
Phone (718) 321-0381
Groups this clinician bills Medicare through
Medicare paid, 2024
$47K
1,355 services
Medicare patients, 2024
92
Average age 75
Drug cost, 2024
$11.6M
3,162 prescriptions
Company payments, 2025
$5,257
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Zili He X was code 85025 (blood count), 240 times for 78 patients. In total Zili He X billed 1,355 services in 40 codes, and Medicare paid $47K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-04-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 85025 Blood Count | Office | 240 | 78 | $7.61 | $1,826 |
| 36415 Venipuncture Blood Collection | Office | 238 | 79 | $8.65 | $2,059 |
| 99213 Office E&M - Established | Office | 169 | 63 | $80.02 | $14K |
| 99212 Office E&M - Established | Office | 89 | 16 | $50.33 | $4,479 |
| 99214 Office E&M - Established | Office | 60 | 27 | $113.96 | $6,838 |
| 99204 Office E&M - New | Office | 24 | 24 | $142.78 | $3,427 |
By year: 2022 $76K for 2,582 services; 2023 $79K for 2,601 services; 2024 $47K for 1,355 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 240 | 78 | $7.61 | $1,826 |
| 36415 Venipuncture Blood Collection | 238 | 79 | $8.65 | $2,059 |
Medicare prescription drug claims, 2024
In 2024, the drug Zili He X prescribed most often to Medicare patients was Diphenhydramine Hcl, with 467 prescriptions and refills. In total Zili He X wrote 3,162 Medicare prescriptions that cost $11.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Diphenhydramine Hcl Generic | 467 | 490 | 90 | $1,191 |
| Dexamethasone Sodium Phosphate Generic | 248 | 271 | 63 | $686 |
| Aprepitant Generic | 171 | 171 | 46 | $71K |
| Granisetron Hcl Granisetron Hcl/Pf | 163 | 163 | 44 | $2,026 |
| Famotidine Famotidine/Pf | 162 | 162 | 41 | $170 |
| Tagrisso Osimertinib Mesylate | 137 | 137 | 19 | $2.3M |
| Keytruda Pembrolizumab | 95 | 95 | 18 | $1.0M |
| Xgeva Denosumab | 93 | 97 | 14 | $289K |
| Lupron Depot Leuprolide Acetate | 77 | 119 | 13 | $227K |
| Granisetron Hcl Generic | 74 | 74 | 36 | $554 |
| Leucovorin Calcium Generic | 71 | 71 | 20 | $16K |
| Fluorouracil Generic | 58 | 58 | 19 | $7,020 |
| Xtandi Enzalutamide | 54 | 54 | Under 11 | $721K |
| Oxaliplatin Generic | 51 | 51 | 17 | $20K |
| Famotidine Generic | 49 | 49 | 29 | $28.59 |
Brand drugs: 1,090 claims; generic drugs: 2,072 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Zili He X $5,257 ($5,257 in general payments such as food, travel and fees) from 29 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $2,783.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 9 | $2,783 |
| Janssen Biotech, Inc. JNJ | 10 | $528 |
| Abbvie Inc. ABBV | 3 | $340 |
| E.R. Squibb & Sons, L.L.C. BMY | 7 | $221 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $149 |
| Merck Sharp & Dohme LLC MRK | 5 | $130 |
| Alexion Pharmaceuticals, Inc. AZN | 1 | $130 |
| Alkermes, Inc. ALKS | 1 | $130 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $125 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $87.86 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.